These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36815218)

  • 1. Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis.
    Lee WC; Shih JY; Fang HY; Wu PJ; Fang CY; Chen HC; Fang YN; Chang WT; Chen MC
    Clin Appl Thromb Hemost; 2023; 29():10760296231158585. PubMed ID: 36815218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
    Tanawuttiwat T; Stebbins A; Marquis-Gravel G; Vemulapalli S; Kosinski AS; Cheng A
    J Am Heart Assoc; 2022 Jan; 11(1):e023561. PubMed ID: 34970918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation.
    Butt JH; De Backer O; Olesen JB; Gerds TA; Havers-Borgersen E; Gislason GH; Torp-Pedersen C; Søndergaard L; Køber L; Fosbøl EL
    Eur Heart J Cardiovasc Pharmacother; 2021 Jan; 7(1):11-19. PubMed ID: 31665260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysis.
    Oliveri F; Montalto C; Tua L; Lanzillo G; Compagnoni S; Fasolino A; Gentile FR; Ferlini M; Pepe A; Oltrona Visconti L; Bongiorno A; Leonardi S
    Int J Cardiol; 2022 Oct; 365():123-130. PubMed ID: 35901908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis Assessing Efficacy and Safety of Vitamin K Antagonists Versus Direct Oral Anticoagulants for Atrial Fibrillation After Transcatheter Aortic Valve Implantation.
    Selvaraj V; Khan MS; Mufarrih SH; Kazimuddin M; Waheed MA; Tripathi A; Bavishi C; Hyder ON; Aronow HD; Saad M; Abbott JD
    Am J Cardiol; 2023 Aug; 201():260-267. PubMed ID: 37393728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation.
    Ooi AJQ; Wong C; Tan TWE; Ng TP; Teo YN; Teo YH; Syn NL; Djohan AH; Lim Y; Yeo LLL; Tan BYQ; Chan MY; Poh KK; Kong WKF; Chai P; Yeo TC; Yip JW; Kuntjoro I; Sia CH
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1589-1600. PubMed ID: 35941300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement.
    Alaour B; Ferrari E; Heg D; Tueller D; Pilgrim T; Muller O; Noble S; Jeger R; Reuthebuch O; Toggweiler S; Templin C; Wenaweser P; Nietlispach F; Taramasso M; Huber C; Roffi M; Windecker S; Stortecky S
    JACC Cardiovasc Interv; 2024 Feb; 17(3):405-418. PubMed ID: 38355269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Memon MM; Siddiqui AA; Amin E; Shaikh FN; Khan MS; Doukky R; Krasuski RA
    Catheter Cardiovasc Interv; 2022 Jun; 99(7):2101-2110. PubMed ID: 35476221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta-analysis.
    Chen YF; Liu F; Li XW; Zhang HJ; Liu YG; Lin L
    Clin Cardiol; 2022 Apr; 45(4):401-406. PubMed ID: 35191074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR.
    Kawashima H; Watanabe Y; Hioki H; Kozuma K; Kataoka A; Nakashima M; Nagura F; Nara Y; Yashima F; Tada N; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Mizutani K; Tabata M; Ueno H; Takagi K; Yamamoto M; Hayashida K;
    JACC Cardiovasc Interv; 2020 Nov; 13(22):2587-2597. PubMed ID: 33129818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Yan J; Liu M; Zhang Y; Yang D; An F
    Clin Cardiol; 2022 Oct; 45(10):1002-1010. PubMed ID: 36030549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis Comparing Direct Oral Anticoagulants Versus Vitamin K Antagonists After Transcatheter Aortic Valve Implantation.
    Ueyama H; Kuno T; Ando T; Briasoulis A; Fox J; Hayashida K; Takagi H
    Am J Cardiol; 2020 Apr; 125(7):1102-1107. PubMed ID: 31964500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients　- A Subanalysis of the ENVISAGE-TAVI AF Trial.
    Watanabe Y; Hayashida K; Yamamoto M; Yamanaka F; Yamasaki K; Naganuma T; Ohno Y; Yamawaki M; Morioka N; Mizutani K; Tada N; Ueno H; Nishina H; Izumo M; Nakajima Y; Ando K; Takagi K; Kimura T; Sugio K; Dangas G; Van Mieghem NM; Hengstenberg C; Chen C; Jin J; Unverdorben M; Saito S
    Circ J; 2022 Oct; 86(11):1756-1763. PubMed ID: 35965066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement.
    Jochheim D; Barbanti M; Capretti G; Stefanini GG; Hapfelmeier A; Zadrozny M; Baquet M; Fischer J; Theiss H; Todaro D; Chieffo A; Presbitero P; Colombo A; Massberg S; Tamburino C; Mehilli J
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1566-1576. PubMed ID: 31202946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Evidence-Based Approach to Anticoagulation Therapy Comparing Direct Oral Anticoagulants and Vitamin K Antagonists in Patients With Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
    Suppah M; Kamal A; Saadoun R; Baradeiya AMA; Abraham B; Alsidawi S; Sorajja D; Fortuin FD; Arsanjani R
    Am J Cardiol; 2023 Nov; 206():132-150. PubMed ID: 37703679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation.
    Kapadia SR; Krishnaswamy A; Whisenant B; Potluri S; Iyer V; Aragon J; Gideon P; Strote J; Leonardi R; Agarwal H; Larrain G; Sanchez C; Panaich SS; Harvey J; Vahl T; Menon V; Wolski K; Wang Q; Leon MB
    Circulation; 2024 Mar; 149(10):734-743. PubMed ID: 37874908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.